10 Under-the-Radar Stocks with Massive Upside for 2025

1. Novavax, Inc. (NYSE:NVAX)

Upside Potential: 88.46%

Stock Price as of January 18: $8.49

Number of Hedge Fund Investors: 25

Novavax, Inc. (NYSE:NVAX) is a leading biotechnology company dedicated to the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. The company uses proprietary protein and nanoparticle technologies, along with its Matrix-M adjuvant to develop vaccines that have the potential to address significant unmet medical needs.

Novavax, Inc. (NYSE:NVAX) has recently entered into a strategic partnership with Sanofi, a global leader in vaccine development and commercialization. This partnership, which includes a license and collaboration agreement, is a cornerstone of the company’s growth strategy. Sanofi will take the lead in co-commercializing Novavax, Inc.’s (NYSE:NVAX) COVID-19 vaccine starting in 2025, allowing the company to monetize its existing vaccine program through royalties and potential milestone payments.

Novavax, Inc. (NYSE:NVAX) is actively advancing its late-stage pipeline, which includes the development of a COVID-19 Influenza Combination (CIC) vaccine and a standalone influenza vaccine. The CIC vaccine represents a significant market opportunity, as combination vaccines can provide broader protection and convenience for patients. The company has recently received clearance from the U.S. FDA to proceed with a Phase 3 immunogenicity trial for both the CIC and standalone influenza vaccine candidates.

While we acknowledge the potential of Novavax, Inc. (NYSE:NVAX) to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than NVAX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.